Envestnet Portfolio Solutions’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.4M Buy
10,251
+2,019
+25% +$248K 0.01% 586
2026
Q1
$970K Buy
8,232
+5,582
+211% +$780K 0.01% 642
2025
Q4
$434K Buy
+2,650
New +$415K ﹤0.01% 1117
2025
Q3
– Sell
-1,693
Closed -$211K – 1555
2025
Q2
$211K Sell
1,693
-405
-19% -$51.5K ﹤0.01% 1487
2025
Q1
$267K Sell
2,098
-1,345
-39% -$207K ﹤0.01% 1352
2024
Q4
$496K Sell
3,443
-73
-2% -$10.5K ﹤0.01% 1245
2024
Q3
$523K Buy
3,516
+47
+1% +$6.74K ﹤0.01% 1180
2024
Q2
$437K Sell
3,469
-265
-7% -$41.5K ﹤0.01% 1198
2024
Q1
$687K Sell
3,734
-187
-5% -$35.6K ﹤0.01% 987
2023
Q4
$705K Buy
3,921
+245
+7% +$38.1K ﹤0.01% 910
2023
Q3
$585K Buy
+3,676
New +$601K ﹤0.01% 922

Other funds holding RGEN

Envestnet Portfolio Solutions's RGEN Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its Repligen (RGEN) stake by 25% in Q2 2026, buying an estimated $248K and bringing the position to 10,251 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #586.

Envestnet Portfolio Solutions first reported a position in RGEN in Q3 2023 and has held it in 11 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Envestnet Portfolio Solutions held 10,251 shares of Repligen worth $1.4M as of Q2 2026.
  • Envestnet Portfolio Solutions bought 2,019 Repligen shares in Q2 2026, an estimated $248K.
  • Repligen made up 0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #586 holding.
  • Envestnet Portfolio Solutions first reported a position in Repligen in Q3 2023 and has held it in 11 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.